Federal Register / Vol. 63, No. 77 /Wednesday, April 22, 1998 / Notices 19921

determine whether a prospective

contractor is responsible by obtaining

information regarding financial and

other capabilities of the prospective

contractor.

B. Annual Reporting Burden

Respondents: 2,200; annual

responses: 2,200; average hours per

response: 1; burden hours: 2,200.

Copy of proposal: A copy of this

proposal may be obtained from the GSA

Acquisition Policy Division (MVP),

Room 4011, GSA Building, 1800 F

Street NW, Washington, DC 20405, or by

telephoning (202) 501–3822, or by

faxing your request to (202) 501–3341.

Dated: April 15, 1998.

Ida M. Ustad,

Deputy Associate Administrator for

Acquisition Policy.

[FR Doc. 98–10638 Filed 4–21–98; 8:45 am]

BILLING CODE 6820–61–M

GENERAL SERVICES

ADMINISTRATION

[OMB Control No. 3090–0200]

Submission for OMB Review;

Comment Request Entitled Sealed

Bidding

AGENCY: Office of Acquisition Policy,

GSA.

ACTION: Notice of request for public

comments regarding reinstatement to a

previously approved OMB clearance

(3090–0200).

SUMMARY: Under the provisions of the

Paperwork Reduction Act of 1995 (44

U.S.C. Chapter 35), the Office of

Acquisition Policy has submitted to the

Office of Management and Budget

(OMB) a request to review and approve

a reinstatement of a previously

approved information collection

requirement concerning Sealed Bidding.

DATES: Comment due date: June 22,

1998.

FOR FURTHER INFORMATION CONTACT: Al

Matera, Office of GSA Acquisition

Policy, (202) 501–1224.

ADDRESSES: Comments regarding this

burden estimate or any other aspect of

this collection of information, including

suggestions for reducing this burden,

should be submitted to: Edward

Springer, GSA Desk Officer, Room 3235,

NEOB, Washington, DC 20503, and to

Marjorie Ashby, General Services

Administration (MVP), 1800 F Street

NW, Washington, DC 20405.

SUPPLEMENTARY INFORMATION:

A. Purpose

The GSA is requesting the Office of

Management and Budget (OMB) to

reinstate information collection, 3090–

0200, Sealed Bidding. The information

requested regarding an offeror’s monthly

production capability is needed to make

progressive awards to ensure coverage

of stock items.

B. Annual Reporting Burden

Respondents: 20; annual responses:

20; average hours per response: .10;

burden hours: 3.3.

Copy of proposal: A copy of this

proposal may be obtained from the GSA

Acquisition Policy Division (MVP),

Room 4011, GSA Building, 1800 F

Street NW, Washington, DC 20405, or by

telephoning (202) 501–3822, or by

faxing your request to (202) 501–3341.

Dated: April 15, 1998.

Ida M. Ustad,

Deputy Associate Administrator for

Acquisition Policy.

[FR Doc. 98–10639 Filed 4–21–98; 8:45 am]

BILLING CODE 6820–61–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made a final finding of scientific

misconduct in the following case:

Cynthia King, Bienville Medical Group

Based on an investigation conducted

by ORI’s Division of Research

Investigations, ORI found that Ms. King,

staff assistant, Bienville Medical Group,

engaged in scientific misconduct in

clinical research conducted as part of a

multicenter clinical trial supported by a

National Heart, Lung, and Blood

Institute (NHLBI), National Institutes of

Health (NIH) contract. Ms. King falsified

and/or fabricated data and information

collected from patients for the

Antihypertensive and Lipid-Lowering

Treatment to Prevent Heart Attack Trial

(ALLHAT) at the clinical site in Terry,

Mississippi. ORI acknowledges Ms.

King’s cooperation and assistance in

completing its investigation.

Ms. King has accepted the ORI finding

and has entered into an Agreement with

ORI in which she has voluntarily

agreed, for the three (3) year period

beginning April 6, 1998:

(1) To exclude herself from serving in

any advisory capacity to the Public

Health Service (PHS), including but not

limited to service on any PHS advisory

committee, board, and/or peer review

committee, or as a consultant; and

(2) That any institution that submits

an application for PHS support for a

research project on which Ms. King’s

participation is proposed or which uses

her in any capacity on PHS supported

research or that submits a report of PHSfunded research in which she is

involved must concurrently submit a

plan for supervision of her duties to the

funding agency for approval. The

supervisory plan must be designed to

ensure the scientific integrity of Ms.

King’s research contribution. The

institution also must submit a copy of

the supervisory plan to ORI.

No scientific publications were

required to be corrected as part of this

Agreement.

FOR FURTHER INFORMATION CONTACT:

Acting Director, Division of Research

Investigations, Office of Research

Integrity, 5515 Security Lane, Suite 700,

Rockville, MD 20852, (301) 443–5330.

Chris B. Pascal,

Acting Director, Office of Research Integrity.

[FR Doc. 98–10660 Filed 4–21–98; 8:45 am]

BILLING CODE 4160–17–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made a final finding of scientific

misconduct in the following case:

Patrina Lowe, Bienville Medical Group

Based on an investigation conducted

by ORI’s Division of Research

Investigations, ORI found that Ms.

Lowe, former staff member, Bienville

Medical Group, engaged in scientific

misconduct in clinical research

conducted as part of a multicenter

clinical trial supported by a National

Heart, Lung, and Blood Institute

(NHLBI), National Institutes of Health

(NIH) contract. Ms. Lowe falsified and/

or fabricated data and information

collected from patients for the

Antihypertensive and Lipid-Lowering

Treatment to Prevent Heart Attack Trial

(ALLHAT) at the clinical site in Terry,

Mississippi. ORI acknowledges Ms.
19922 Federal Register / Vol. 63, No. 77 /Wednesday, April 22, 1998 / Notices

Lowe’s cooperation and assistance in

completing its investigation.

Ms. Lowe has accepted the ORI

finding and has entered into an

Agreement with ORI in which she has

voluntarily agreed, for the three (3) year

period beginning April 6, 1998:

(1) To exclude herself from serving in

any advisory capacity to the Public

Health Service (PHS), including but not

limited to service on any PHS advisory

committee, board, and/or peer review

committee, or as a consultant; and

(2) That any institution that submits

an application for PHS support for a

research project on which Ms. Lowe’s

participation is proposed or which uses

her in any capacity on PHS supported

research or that submits a report of PHSfunded research in which she is

involved must concurrently submit a

plan for supervision of her duties to the

funding agency for approval. The

supervisory plan must be designed to

ensure the scientific integrity of Ms.

Lowe’s research contribution. The

institution also must submit a copy of

the supervisory plan to ORI.

No scientific publications were

required to be corrected as part of this

Agreement.

FOR FURTHER INFORMATION CONTACT:

Acting Director, Division of Research

Investigations, Office of Research

Integrity, 5515 Security Lane, Suite 700,

Rockville, MD 20852, (301) 443–5330.

Chris B. Pascal,

Acting Director, Office of Research Integrity.

[FR Doc. 98–10575 Filed 4–21–98; 8:45 am]

BILLING CODE 4160–17–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–13–98]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

1. Provider Survey of Partner

Notification and Partner Management

Practices following Diagnosis of a

Sexually-Transmitted Disease—New—

The National Center for HIV, STD, and

TB Prevention, Division of STD

Prevention. CDC is proposing to

conduct a national survey of physician’s

partner management practices following

the diagnosis of a sexually-transmitted

disease. Partner notification, a

technique for controlling the spread of

sexually-transmitted diseases, is one of

the five key elements of a long-standing

public health strategy to control

sexually-transmitted infections in the

U.S. At present, there is very little

knowledge about partner notification

practices outside public health settings

despite the fact that most STD cases are

seen in private health care settings. No

descriptive data currently exists that

allows the Centers for Disease Control

and Prevention to characterize partner

notification practices among the broad

range of clinical practice settings where

STDs are diagnosed, including acute or

urgent care, emergency room, or

primary and ambulatory care clinics.

The existing literature contains

descriptive studies of partner

notification in public health clinics, but

no baseline data exists as to the

practices of different physician

specialties across different practice

settings.

The CDC proposes to fill that gap

through a national sample survey of

7300 office managers and physicians

who treat patients with STDs in a wide

variety of clinical settings; a 70%

completion rate is anticipated (n=5110

surveys). This survey will provide the

baseline data necessary to characterize

infection control practices, especially

partner notification practices, for

syphilis, gonorrhea, HIV, and

chlamydia, and the contextual factors

that influence those practices. Findings

from the proposed national survey of

office managers and physicians will

assist CDC to better focus STD control

and partner notification program efforts

and to allocate program resources

appropriately. Without this information,

CDC will have little information about

STD treatment, reporting, and partner

management services provided by

physicians practicing in the U.S. With

changes underway in the manner in

which medical care is delivered and the

move toward managed care, clinical

functions typically provided in the

public health sector will now be

required of private medical providers.

At present, CDC does not have sufficient

information to guide future STD control

efforts in the private medical sector.

Data collection will involve a mail

survey of practicing physicians. The

questionnaire mailing will be followed

by a reminder postcard after one week,

a second mailing to non-respondents at

three weeks, telephone follow-up with

non-respondents at five weeks, and a

final certified mailing of the survey to

non-respondents at eight weeks. A study

specific computerized tracking and

reporting system will monitor all phases

of the study. Receipt of the completed

questionnaire or a refusal will be logged

into this computerized control system to

ensure that respondents who return the

survey are not contacted with

reminders. Total annual burden hours

are 2,555.

Respondents Sections Number of

respondents

Number of

responses/

respondent

Average burden/response

(in hrs.)

Total burden

(in hrs.)

Physicians ........................................................................... 2–4 5110 1 .083 426

Physicians ........................................................................... 5–10 5110 1 .417 2,129